Preliminary Examination of the Reliability and Concurrent Validity of the Attention-Deficit/Hyperactivity Disorder Self-Report Scale v1.1 Symptom Checklist to Rate Symptoms of Attention-Deficit/Hyperactivity Disorder in Adolescents
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To validate the attention-deficit/hyperactivity disorder (ADHD) Self-Report Scale (ASRS) v1.1 Symptom Checklist versus the clinician-administered ADHD Rating Scale (ADHD-RS) in adolescents with ADHD. METHOD: A total of 88 adolescents with ADHD aged 13-17 years participated in the study. The study was completed in one or two visits, 1-9 weeks apart. At each visit, participants completed the ASRS v1.1 Symptom Checklist, after which raters administered the ADHD-RS. Internal consistency of the ASRS v1.1 Symptom Checklist was assessed by Cronbach's alpha (Cronbach's α). Concurrent validity between the scales was assessed using Pearson's correlation coefficients. Item-by-item reliability between the scales was assessed by the Kappa coefficient of agreement. RESULTS: The mean age of participants was 14.9±1.5 SD years. 76.1% (n=67) were male. 73.9% (n=65) were currently receiving medication for ADHD. Internal consistency of ASRS v1.1 Symptom Checklist items was high, with Cronbach's α coefficients of 0.93 at Visit 1 and 0.94 at Visit 2. Pearson's correlation coefficients between the ASRS v1.1 Symptom Checklist and ADHD-RS were highly significant at Visit 1 (r=0.72, p<0.0001) and Visit 2 (r=0.73, p<0.0001). There was moderate item-by-item agreement between individual items on the scales (% agreement: 35.2%-63.4%) with statistically significant kappa coefficients for 17 of the 18 items. CONCLUSION: The ASRS v1.1 Symptoms Checklist showed high internal consistency and high concurrent validity with the clinician-administered ADHD-RS in adolescents with ADHD. Results of this study suggest that the ASRS v1.1 Symptom Checklist is an internally consistent self-report scale for the assessment of adolescent ADHD and is moderately associated with a concurrently administered clinician measure of ADHD symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886 · cited 1×
“Approximately 50%–75% of children continue to meet criteria for ADHD as adolescents (Dulcan 1997), with about 50%– 60% continuing to have the disorder as adults (Brown 2000; Kessler et al. 2006).”
Self-citationKESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 2×
“1 Symptom Checklist is an 18-item scale developed by the workgroup on adult ADHD for the World Health Organization (WHO) as a means for providing a valid self-assessment of ADHD symptoms (Kessler et al. 2005).”
Self-citation(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.564 · Cited by 1,738 · cited 1×
“…to experience deficits in behavioral, emotional, interpersonal, and social functioning (Barkley et al. 1990, 1991; Mannuzza and Klein 1999), in addition to high rates of co-morbid psychiatric disorders such as mood, anxiety, conduct, and substance use disorders (Biederman et al. 1991, 1992, 1996).”
Self-citationBARKLEY, R. A., FISCHER, M., EDELBROCK, C. S., & SMALLISH, L. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199007000-00007 · Cited by 1,507 · cited 1×
“Adolescents with ADHD continue to experience deficits in behavioral, emotional, interpersonal, and social functioning (Barkley et al. 1990, 1991; Mannuzza and Klein 1999), in addition to high rates of co-morbid psychiatric disorders such as mood, anxiety, conduct, and substance use disorders…”
Biederman, J. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090056010 · Cited by 771
Validity of pilot Adult ADHD Self-Report Scale (ASRS) to rate adult ADHD symptoms
Adler, L. A., Spencer, T., Faraone, S. V., Kessler, R. C., Howes, M. J., Biederman, J., & Secnik, K. (2006) · Annals of Clinical Psychiatry · doi:10.1080/10401230600801077 · Cited by 677 · cited 2×
“Approximately 50%–75% of children continue to meet criteria for ADHD as adolescents (Dulcan 1997), with about 50%– 60% continuing to have the disorder as adults (Brown 2000; Kessler et al. 2006).”
Self-citationMichelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Self-citationDulcan, M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199710001-00007 · Cited by 628
Kelsey, D. K., Sumner, C. R., Casat, C. D., Coury, D. L., Quintana, H., Saylor, K. E., Sutton, V. K., Gonzales, J., Malcolm, S. K., Schuh, K. J., et al. (2004) · Pediatrics · doi:10.1542/peds.114.1.e1 · Cited by 464 · cited 1×
“…trials of osmotic-release oral system (OROS) methylphenidate (Wilens et al. 2006a, 2006b), atomoxetine (Michelson et al. 2001; Spencer et al. 2002; Kelsey et al. 2004), and lisdexamfetamine dimesylate (Biederman et al. 2007; Findling et al. 2008, 2011) in children and adolescents with ADHD.”
Biederman, J., Krishnan, S., Zhang, Y., McGough, J. J., & Findling, R. L. (2007) · Clinical Therapeutics · doi:10.1016/s0149-2918(07)80083-x · Cited by 404
Spencer, T., Heiligenstein, J. H., Biederman, J., Faries, D. E., Kratochvil, C. J., Conners, C. K., & Potter, W. Z. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1209 · Cited by 333 · cited 1×
“…measure in clinical trials of osmotic-release oral system (OROS) methylphenidate (Wilens et al. 2006a, 2006b), atomoxetine (Michelson et al. 2001; Spencer et al. 2002; Kelsey et al. 2004), and lisdexamfetamine dimesylate (Biederman et al. 2007; Findling et al. 2008, 2011) in children and…”
Self-citationKessler, R. C., Green, J. G., Adler, L. A., Barkley, R. A., Chatterji, S., Faraone, S. V., Finkelman, M., Greenhill, L. L., Gruber, M. J., Jewell, M., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.146 · Cited by 317 · cited 1×
“…which is partially due to the higher cognitive demands of adolescence and adulthood and that overt hyperactive symptoms are more often felt internally rather than externally manifested (Millstein et al. 1997; Weiss and Jain 2000; Murphy and Adler 2004; Kessler et al. 2010; Goodman et al. 2011).”
Self-citationDiagnosis and evaluation of adults with attention-deficit/hyperactivity disorder
Adler, L., & Cohen, J. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2003.12.003 · Cited by 290
Self-citationWilens, T. E., McBurnett, K., Bukstein, O., McGough, J., Greenhill, L., Lerner, M., Stein, M. A., Conners, C. K., Duby, J., Newcorn, J., et al. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.1.82 · Cited by 160
Self-citationFindling, R. L., Childress, A. C., Cutler, A. J., Gasior, M., Hamdani, M., Ferreira-Cornwell, M. C., & Squires, L. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.01.007 · Cited by 120 · cited 1×
“…trials of osmotic-release oral system (OROS) methylphenidate (Wilens et al. 2006a, 2006b), atomoxetine (Michelson et al. 2001; Spencer et al. 2002; Kelsey et al. 2004), and lisdexamfetamine dimesylate (Biederman et al. 2007; Findling et al. 2008, 2011) in children and adolescents with ADHD.”
Findling, R. L., Childress, A. C., Krishnan, S., & McGough, J. J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016898 · Cited by 90
Cited by
Ra, C. K., Cho, J., Stone, M. D., De La Cerda, J., Goldenson, N. I., Moroney, E., Tung, I., Lee, S. S., & Leventhal, A. M. (2018) · JAMA · doi:10.1001/jama.2018.8931 · Cited by 360
Sivertsen, B., Harvey, A. G., Pallesen, S., & Hysing, M. (2015) · Journal of Sleep Research · doi:10.1111/jsr.12254 · Cited by 158
Sleep problems and self-harm in adolescence
Hysing, M., Sivertsen, B., Stormark, K. M., & O'Connor, R. C. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.146514 · Cited by 114
Sivertsen, B., Skogen, J. C., Jakobsen, R., & Hysing, M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.045 · Cited by 83
Becker, S. P., Burns, G. L., Smith, Z. R., & Langberg, J. M. (2020) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-019-00603-9 · Cited by 81
Metadata
- Authors
- Adler, L. A., Shaw, D. M., Spencer, T. J., Newcorn, J. H., Hammerness, P., Sitt, D. J., Minerly, C., Davidow, J. V., & Faraone, S. V.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2012-06
- Volume
- 22
- Issue
- 3
- Pages
- 238-244
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2085870884
- Cited by
- 100
- References
- 17
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.